3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
15
Unknown
4
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
36
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Burkitt Lymphoma
7
Neoplasms
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Leukemia
6
Lymphoma, B-Cell
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Neoplasm Metastasis
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Pain
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Lymphatic Diseases
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Neoplasms
2
Hematologic Diseases
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumours
1
Sezary Syndrome
1
Interventions
Melphalan
16
Cyclophosphamide
14
Dexamethasone
13
fludarabine phosphate
12
Filgrastim
11
Antilymphocyte Serum
11
fludarabine
8
Radiotherapy
8
Mycophenolic Acid
8
Cyclosporine
8
Busulfan
8
Whole-Body Irradiation
7
Tacrolimus
7
Peripheral Blood Stem Cell Transplantation
7
Methylprednisolone
6
Lenalidomide
6
Bortezomib
6
pomalidomide
5
Rituximab
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Cord Blood Stem Cell Transplantation
5
Calcium Dobesilate
5
Flow Cytometry
4
Etoposide
4
Arsenic Trioxide
4
liposomal doxorubicin
3
Thalidomide
3
Surveys and Questionnaires
3
Stem Cell Transplantation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Plasma Cell
×
Prednisone
×
Clear all
NCT01116128
2011-06-14
D-MP
Fondazione EMN Italy Onlus
Phase 2
Terminated
8 enrolled